carboxyatractyloside has been researched along with 4-hydroxy-2-nonenal in 1 studies
Studies (carboxyatractyloside) | Trials (carboxyatractyloside) | Recent Studies (post-2010) (carboxyatractyloside) | Studies (4-hydroxy-2-nonenal) | Trials (4-hydroxy-2-nonenal) | Recent Studies (post-2010) (4-hydroxy-2-nonenal) |
---|---|---|---|---|---|
261 | 0 | 22 | 3,034 | 26 | 1,103 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguirre, E; Cadenas, S | 1 |
1 other study(ies) available for carboxyatractyloside and 4-hydroxy-2-nonenal
Article | Year |
---|---|
GDP and carboxyatractylate inhibit 4-hydroxynonenal-activated proton conductance to differing degrees in mitochondria from skeletal muscle and heart.
Topics: Aldehydes; Animals; Atractyloside; Blotting, Western; Cysteine Proteinase Inhibitors; Electron Transport Complex IV; Female; Guanosine Diphosphate; Lipopolysaccharides; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondria, Heart; Mitochondria, Muscle; Mitochondrial ADP, ATP Translocases; Muscle, Skeletal; Oxygen Consumption; Protons | 2010 |